• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪氨酸激酶的致癌激活

Oncogenic activation of tyrosine kinases.

作者信息

Rodrigues G A, Park M

机构信息

McGill University, Montreal, Canada.

出版信息

Curr Opin Genet Dev. 1994 Feb;4(1):15-24. doi: 10.1016/0959-437x(94)90086-8.

DOI:10.1016/0959-437x(94)90086-8
PMID:8193535
Abstract

Tyrosine kinases comprise the largest group of oncoproteins, a fact that underscores the importance of reversible tyrosine phosphorylation in the regulation of essential cellular functions. Oncogenic activation of tyrosine kinases results in the constitutive activation of what is normally a conditionally regulated enzyme activity. Studies of tyrosine kinase oncoproteins, and a comparison with their corresponding proto-oncogene products, have identified important functional and regulatory domains within these proteins, positive and negative regulators of their enzyme activities and signalling cascades that control cell growth and differentiation.

摘要

酪氨酸激酶构成了最大的一类癌蛋白,这一事实凸显了可逆性酪氨酸磷酸化在调节基本细胞功能中的重要性。酪氨酸激酶的致癌激活导致通常受条件调节的酶活性的组成性激活。对酪氨酸激酶癌蛋白的研究以及与它们相应的原癌基因产物的比较,已经确定了这些蛋白内重要的功能和调节结构域、它们酶活性的正负调节因子以及控制细胞生长和分化的信号级联反应。

相似文献

1
Oncogenic activation of tyrosine kinases.酪氨酸激酶的致癌激活
Curr Opin Genet Dev. 1994 Feb;4(1):15-24. doi: 10.1016/0959-437x(94)90086-8.
2
Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.致癌病毒酪氨酸蛋白激酶的大多数底物在正常细胞中可被细胞酪氨酸蛋白激酶磷酸化。
Oncogene Res. 1988 Sep;3(2):105-15.
3
Oncogenic kinase signalling.致癌激酶信号传导
Nature. 2001 May 17;411(6835):355-65. doi: 10.1038/35077225.
4
Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.在培养的纹状体神经元中,抑制Src家族酪氨酸激酶活性可阻断谷氨酸向细胞外信号调节激酶1/2(ERK1/2)和蛋白激酶B(Akt/PKB)的信号传导,但不影响应激活化蛋白激酶(JNK)。
J Neurochem. 2004 Mar;88(5):1127-39. doi: 10.1046/j.1471-4159.2004.02257.x.
5
Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.酪氨酸激酶结构域中的点突变释放了Ron受体的致癌和转移潜能。
Oncogene. 1998 Aug 13;17(6):741-9. doi: 10.1038/sj.onc.1201994.
6
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.RET/PTC(在转化/甲状腺乳头状癌中重排)酪氨酸激酶使磷酸肌醇依赖性激酶1(PDK1)磷酸化并激活:一条独立于磷脂酰肌醇3激酶激活PDK1的替代途径。
Mol Endocrinol. 2003 Jul;17(7):1382-94. doi: 10.1210/me.2002-0402. Epub 2003 May 8.
7
New impressions of Src and Hck.Src和Hck的新见解
Nature. 1997 Feb 13;385(6617):582-3, 585. doi: 10.1038/385582b0.
8
Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.Src家族激酶在Fcγ受体介导的吞噬作用中的差异参与。
J Immunol. 2000 Jul 1;165(1):473-82. doi: 10.4049/jimmunol.165.1.473.
9
Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.通过SH3结构域置换激活Src家族酪氨酸激酶Hck
Nature. 1997 Feb 13;385(6617):650-3. doi: 10.1038/385650a0.
10
Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat 1a cells.由NIH 3T3和大鼠1a细胞中选择性癌基因表达导致的丝裂原活化蛋白激酶激活。
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7355-9. doi: 10.1073/pnas.89.16.7355.

引用本文的文献

1
Comprehensive genomic characterization of hematologic malignancies at a pediatric tertiary care center.一家儿科三级护理中心血液系统恶性肿瘤的综合基因组特征分析
Front Oncol. 2024 Dec 2;14:1498409. doi: 10.3389/fonc.2024.1498409. eCollection 2024.
2
Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review.小分子酪氨酸激酶抑制剂诱导的血糖异常:综述
Front Pharmacol. 2024 Feb 1;15:1355171. doi: 10.3389/fphar.2024.1355171. eCollection 2024.
3
Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
TPR介导的致癌融合激酶寡聚化与激活的结构基础
Structure. 2017 Jun 6;25(6):867-877.e3. doi: 10.1016/j.str.2017.04.015. Epub 2017 May 18.
4
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.受体酪氨酸激酶(c-Kit)抑制剂:癌细胞中的一个潜在治疗靶点。
Drug Des Devel Ther. 2016 Aug 1;10:2443-59. doi: 10.2147/DDDT.S89114. eCollection 2016.
5
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.激活环酪氨酸823对于c-Kit致癌突变体D816V的转化能力至关重要。
Oncogene. 2015 Aug 27;34(35):4581-90. doi: 10.1038/onc.2014.383. Epub 2014 Dec 1.
6
Identification of a recurrent STRN/ALK fusion in thyroid carcinomas.甲状腺癌中一种复发性STRN/ALK融合的鉴定。
PLoS One. 2014 Jan 27;9(1):e87170. doi: 10.1371/journal.pone.0087170. eCollection 2014.
7
SH3 domain tyrosine phosphorylation--sites, role and evolution.SH3 结构域酪氨酸磷酸化——位点、作用与进化。
PLoS One. 2012;7(5):e36310. doi: 10.1371/journal.pone.0036310. Epub 2012 May 15.
8
Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.致癌酪氨酸激酶将 Dok-1 作为泛素化介导的蛋白酶体降解的靶标,以促进细胞转化。
Mol Cell Biol. 2011 Jul;31(13):2552-65. doi: 10.1128/MCB.05045-11. Epub 2011 May 2.
9
(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase.(-)-表没食子儿茶素没食子酸酯通过抑制ZAP-70激酶调节白血病中CD3介导的T细胞受体信号传导。
J Biol Chem. 2008 Oct 17;283(42):28370-9. doi: 10.1074/jbc.M802200200. Epub 2008 Aug 7.
10
Cell kinetics and cell cycle regulation in lymphomas.淋巴瘤中的细胞动力学与细胞周期调控
J Clin Pathol. 2002 Sep;55(9):648-55. doi: 10.1136/jcp.55.9.648.